Literature DB >> 10742018

More trials on early treatment with corticosteroids are needed.

N V Subhedar, A J Bennett, S P Wardle, N J Shaw.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 10742018      PMCID: PMC1117853     

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  3 in total

1.  Postnatal dexamethasone in preterm infants is potentially lifesaving, but follow up studies are urgently needed.

Authors:  W Tarnow-Mordi; A Mitra
Journal:  BMJ       Date:  1999-11-27

2.  Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants.

Authors:  N V Subhedar; S W Ryan; N J Shaw
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-11       Impact factor: 5.747

3.  Early dexamethasone therapy in preterm infants: a follow-up study.

Authors:  T F Yeh; Y J Lin; C C Huang; Y J Chen; C H Lin; H C Lin; W S Hsieh; Y J Lien
Journal:  Pediatrics       Date:  1998-05       Impact factor: 7.124

  3 in total
  7 in total

1.  Hazards of systemic steroids for ventilator-dependent preterm infants: what would a parent want?

Authors:  K J Barrington
Journal:  CMAJ       Date:  2001-07-10       Impact factor: 8.262

2.  Death or neurodevelopmental impairment at 18 to 22 months corrected age in a randomized trial of early dexamethasone to prevent death or chronic lung disease in extremely low birth weight infants.

Authors:  Ann R Stark; Waldemar A Carlo; Betty R Vohr; Lu Ann Papile; Shampa Saha; Charles R Bauer; William Oh; Seetha Shankaran; Jon E Tyson; Linda L Wright; W Kenneth Poole; Abhik Das; Barbara J Stoll; Avroy A Fanaroff; Sheldon B Korones; Richard A Ehrenkranz; David K Stevenson; Myriam Peralta-Carcelen; Deanne E Wilson-Costello; Henrietta S Bada; Roy J Heyne; Yvette R Johnson; Kimberly Gronsman Lee; Jean J Steichen
Journal:  J Pediatr       Date:  2013-08-27       Impact factor: 4.406

3.  Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants.

Authors: 
Journal:  Paediatr Child Health       Date:  2002-01       Impact factor: 2.253

Review 4.  Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.

Authors:  Lex W Doyle; Jeanie L Cheong; Susanne Hay; Brett J Manley; Henry L Halliday
Journal:  Cochrane Database Syst Rev       Date:  2021-11-11

Review 5.  Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.

Authors:  Lex W Doyle; Jeanie L Cheong; Susanne Hay; Brett J Manley; Henry L Halliday
Journal:  Cochrane Database Syst Rev       Date:  2021-10-21

Review 6.  Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.

Authors:  Lex W Doyle; Jeanie L Cheong; Richard A Ehrenkranz; Henry L Halliday
Journal:  Cochrane Database Syst Rev       Date:  2017-10-24

Review 7.  The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs.

Authors:  K J Barrington
Journal:  BMC Pediatr       Date:  2001-02-27       Impact factor: 2.125

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.